Literature DB >> 9014863

Differential growth of N- and S-type human neuroblastoma cells xenografted into scid mice. correlation with apoptosis.

M Piacentini1, L Piredda, D T Starace, M Annicchiarico-Petruzzelli, M Mattei, S Oliverio, M G Farrace, G Melino.   

Abstract

This study concerns the role of apoptosis in the growth of human neuroblastomas transplanted into immunodeficient SCID mice. Human neuroblastoma cell lines may consist of one or more distinct phenotypes including the neural 'N-type' and flat substrate-adherent 'S-type'. A differential phenotype-specific proliferation was apparent among S- and N-type cell clones transplanted into SCID mice when compared with the wild-type SK-N-BE(2) cell line. This differential growth capacity of the tumours was correlated with spontaneous apoptosis. Another SK-N-BE(2)-derived cell line (TGA), displaying high levels of apoptosis upon stable transfection with the full length 'tissue' transglutaminase (tTG) cDNA, was unable to induce tumour development when xenografted into SCID mice. To support these observations, the expression of apoptosis-related genes (i.e., bcl-2, p53, and tTG) in the various neuroblastomas was also investigated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9014863     DOI: 10.1002/(SICI)1096-9896(199612)180:4<415::AID-PATH684>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

1.  Low extracellular sodium causes neuronal distress independently of reduced osmolality in an experimental model of chronic hyponatremia.

Authors:  Susanna Benvenuti; Cristiana Deledda; Paola Luciani; Giulia Modi; Alessandro Bossio; Corinna Giuliani; Benedetta Fibbi; Alessandro Peri
Journal:  Neuromolecular Med       Date:  2013-05-22       Impact factor: 3.843

2.  Sensitization to TRAIL-induced apoptosis in human neuroblastoma SK-N-AS cells by NF-κB inhibitors is dependent on reactive oxygen species (ROS).

Authors:  Tom Gatsinzi; Kerstin Iverfeldt
Journal:  J Neurooncol       Date:  2011-01-13       Impact factor: 4.130

3.  Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells.

Authors:  L J Wainwright; A Lasorella; A Iavarone
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

4.  Neuronal distress induced by low extracellular sodium in vitro is partially reverted by the return to normal sodium.

Authors:  S Benvenuti; C Deledda; P Luciani; C Giuliani; B Fibbi; M Muratori; A Peri
Journal:  J Endocrinol Invest       Date:  2015-07-14       Impact factor: 4.256

5.  Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma.

Authors:  Xiaoying Shang; Susan M Burlingame; M Fatih Okcu; Ningling Ge; Heidi V Russell; Rachel A Egler; Rodney D David; Sanjeev A Vasudevan; Jianhua Yang; Jed G Nuchtern
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

6.  Biological significance of EPHA2 expression in neuroblastoma.

Authors:  Bing Kung; Huaqing Zhao; Sakeenah L Hicks; Xao X Tang; Naohiko Ikegaki
Journal:  Int J Oncol       Date:  2009-10       Impact factor: 5.650

7.  Gene disruption of tissue transglutaminase.

Authors:  V De Laurenzi; G Melino
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 8.  The role of intracellular calcium for the development and treatment of neuroblastoma.

Authors:  Noothan Jyothi Satheesh; Dietrich Büsselberg
Journal:  Cancers (Basel)       Date:  2015-05-22       Impact factor: 6.639

Review 9.  Glycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies.

Authors:  Nora Berois; Eduardo Osinaga
Journal:  Front Oncol       Date:  2014-05-23       Impact factor: 6.244

10.  Store-operated Ca(2+) entry in proliferating and retinoic acid-differentiated N- and S-type neuroblastoma cells.

Authors:  Natalie Bell; Victoria Hann; Christopher P F Redfern; Timothy R Cheek
Journal:  Biochim Biophys Acta       Date:  2012-12-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.